logo
Plus   Neg
Share
Email

West Pharmaceutical Services To Replace Helmerich & Payne In S&P 500

S&P Dow Jones Indices said that S&P MidCap 400 constituent West Pharmaceutical Services Inc. (WST) will replace Helmerich & Payne Inc. (HP) in the S&P 500.

Helmerich & Payne will replace J.C. Penney Company Inc. (JCP) in the S&P SmallCap 600, and Physicians Realty Trust (DOC) will replace West Pharmaceutical Services in the S&P MidCap 400.

S&P Dow Jones Indices stated that J.C. Penney filed to reorganize under Chapter 11 of the U.S. Bankruptcy Code and is no longer eligible for continued inclusion in the S&P SmallCap 600.

Helmerich & Payne has a market capitalization that is more representative of the small-cap market space.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. retailers Best Buy Co. Inc., Abercrombie & Fitch Co., and Dollar Tree Inc. on Tuesday reported results for the third quarter that surpassed analysts' expectations. The upbeat results indicate that retailers have largely recovered from the impact of the coronavirus pandemic just as the holiday season approaches. The companies have also intensified their focused on digital sales. The U.S. Food and Drug Administration approved the first drug to treat primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder which causes recurrent kidney stones and loss of kidney function. Alnylam Pharmaceuticals' Oxlumo (lumasiran) in the form of injection lowers urinary oxalate levels in pediatric and adult patients. The U.S. federal government's General Services Administration or GSA has awarded a five-year federal transportation contract, estimated to be worth up to $810 million, to Uber Technologies Inc. and Lyft Inc., according to multiple reports. Under the contract, the ride-hailing companies would provide services to various public agencies and their around 4 million employees across the nation.
RELATED NEWS
Follow RTT